Dual-listed engineering, project delivery and operations management group DRA Global has announced the resignation of four of its directors from the company’s board, effective immediately. The ASX- and JSE-listed company on Thursday said that following engagement with the company’s largest shareholder, Apex Partners Holdings, Peter Mansell, Lee Guthrie, Paul Lombard and Sandra Bell had resigned from the company’s board. Bell was only appointed to the board in July of this year.
Articles can be saved for quick future reference. This is a subscriber benefit. If you are already a subscriber, please log in to save this article. If you are not a subscriber, click on the View Subscription Options button to subscribe.
Please enter the email address that you used to subscribe on Engineering News. Your password will be sent to this address.Note: When you select a default region you will be directed to the MiningWeekly.com home page of your choice whenever you visit miningweekly.com. This setting is controlled by cookies and should your cookies be re-set you will then be directed to the regional edition associated with the geographic location of our IP address.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
UNCTAD calls for global action to spur growth by reducing global inequalityThe United Nations Conference on Trade and Development (UNCTAD) has issued its 2023 Trade and Development Report, urging global efforts to revive economic growth.
Read more »
Spacesuits, Research, and Treadmill Work – Space Station Crew Gears Up for Dual SpacewalksScience, Space and Technology News 2023
Read more »
The Google Pixel Fold’s dual-screen interpreter begins rolling outGoogle announced today it will begin rolling out several new Pixel features, including the Pixel Fold’s dual-screen interpreter mode. The novel translation feature, which Engadget tested earlier this year, uses the phone’s folding display to translate both sides of a live conversation.
Read more »
The Rose Hits No. 1 on Emerging Artists Chart Thanks to ‘Dual’ AlbumThe group earns its first leader on any Billboard survey.
Read more »
Double Trouble for Cancer Tumors: The Dual-Action Immunotherapy BreakthroughThe small molecule, now in clinical trials, increases activity of immune cells and sensitivity of tumors to immune attack. Cancer immunotherapy drugs called PD-1 inhibitors are widely used to stimulate the immune system to fight cancer, but many patients either don’t respond or develop resistance
Read more »
The Rose Enters Billboard 200 For 1st Time With “DUAL”The Rose Enters Billboard 200 For 1st Time With “DUAL”
Read more »